Y-mAbs Therapeutics, Inc.

CITADEL ADVISORS LLC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

207,642

Value ($000)

936

Weight

0.0%

2019 Q4 - 2025 Q2 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	936	0.0%	207,642	6/30/2025
2025 Q1	5/15/2025	682	0.0%	153,955	3/31/2025
2024 Q4	2/14/2025	1,738	0.0%	221,914	12/31/2024
2024 Q3	11/14/2024	3,610	0.0%	274,547	9/30/2024
2024 Q2	8/14/2024	3,162	0.0%	261,744	6/30/2024
2024 Q1	5/15/2024	1,924	0.0%	118,301	3/31/2024
2023 Q4	2/14/2024	938	0.0%	137,500	12/31/2023
2023 Q3	11/14/2023	2,258	0.0%	414,307	9/30/2023
2023 Q2	8/14/2023	214	0.0%	31,513	6/30/2023
2023 Q1	5/15/2023	1,532	0.0%	305,710	3/31/2023
2022 Q4	2/14/2023	4,687	0.0%	960,421	12/31/2022
2022 Q3	11/14/2022	1,304	0.0%	90,460	9/30/2022
2022 Q1	5/16/2022	320	0.0%	26,927	3/31/2022
2021 Q4	2/14/2022	2,038	0.0%	125,698	12/31/2021
2021 Q3	11/15/2021	2,983	0.0%	104,515	9/30/2021
2021 Q2	8/16/2021	5,921	0.0%	175,185	6/30/2021
2021 Q1	5/21/2021	2,764	0.0%	91,395	3/31/2021
2020 Q4	2/16/2021	5,717	0.0%	115,469	12/31/2020
2020 Q3	11/16/2020	352	0.0%	9,168	9/30/2020
2020 Q2	8/14/2020	561	0.0%	13,000	6/30/2020
2020 Q1	5/15/2020	990	0.0%	37,913	3/31/2020
2019 Q4	2/14/2020	2,197	0.0%	70,328	12/31/2019